Healthcare -
Biotechnology - NASDAQ - US
$ 9.97
-0.103 %
$ 460 M
Market Cap
-3.26
P/E
URGN - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities URGN - UroGen Pharma Ltd.
-20.6 M
LAST VALUE
-352.18%
2 YEAR CAGR
32.36%
5 YEAR CAGR
-170.03%
10 YEAR CAGR